Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Finland Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20132
20152
20171
20181
20192
20223
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting6
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stichting Hemato-Oncologie voor Volwassenen Nederland5
AbbVie1
Astex Pharmaceuticals, Inc.1
Boehringer Ingelheim1
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
PedAL BCU, LLC1
University of Ulm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute16
Leukemia2
Myelodysplastic Syndromes2
Blast Crisis1
Burkitt Lymphoma1
Dendritic Cell Sarcoma, Interdigitating1
Fever1
Hodgkin Disease1
Hot Flashes1
Infections1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.